Patents Represented by Attorney, Agent or Law Firm Gene J. Yao
  • Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
    Patent number: 6528526
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: March 4, 2003
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Wei He, Alfred P. Spada, Martin P. Maguire